Cargando…

Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit

Antibiotics induced acute kidney injury (AKI) risk in critically ill patients is not well known. This study aimed to evaluate the AKI development and clinical outcomes in critically ill adult patients treated with vancomycin (VAN) or combined with piperacillin-tazobactam (TZP) or meropenem (MEM). Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Soyoung, Park, Jimin, Yu, Yun Mi, Park, Min Soo, Han, Euna, Chang, Min Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550403/ https://www.ncbi.nlm.nih.gov/pubmed/31166993 http://dx.doi.org/10.1371/journal.pone.0217908

Ejemplares similares

Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
por: Kim, Yeon Sook, et al.
Publicado: (2003)

Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?
por: Roger, Claire, et al.
Publicado: (2021)

162. Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
por: Tucker, Kendall J, et al.
Publicado: (2020)

728 Evaluation of Empirical Regimens Including Antistaphylococal Beta-lactam Antibiotics vs Vancomycin Monotherapy on Outcomes of Patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
por: Terico, Adrienne, et al.
Publicado: (2014)

Beta-lactam allergy labeling in intensive care units: An observational, retrospective study
por: Leone, Marc, et al.
Publicado: (2021)

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
por: Aslan, Abdullah Tarık, et al.
Publicado: (2022)

1462. Analysis of Clindamycin and Vancomycin Use and Reported Beta Lactam Allergy in Procedural Antimicrobial Prophylaxis
por: Veach, Lisa A, et al.
Publicado: (2023)

Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity
por: Legg, Amy, et al.
Publicado: (2023)

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011)

Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
por: Reid, Eric, et al.
Publicado: (2021)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care
por: Dolly, Lauren M., et al.
Publicado: (2023)

2402. Evaluating Clinical Outcomes of Adjunctive Beta-Lactam Use in Vancomycin-Resistant Enterococcus Infective Endocarditis
por: Khan, Ebrahim H, et al.
Publicado: (2023)

Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury
por: Kim, Sang-Mi, et al.
Publicado: (2021)

Epidemiology and Control of an Outbreak of Vancomycin-Resistant Enterococci in the Intensive Care Units
por: Yoon, Young Kyung, et al.
Publicado: (2009)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

129. Beta-lactam vs Fluoroquinolone Monotherapy for pseudomonas Aeruginosa infection: A Systematic Review and Meta-analysis
por: Reid, Eric C, et al.
Publicado: (2020)

1294. A survey on Vancomycin and Beta Lactams usage in critical care settings in Makkah, Kingdom of Saudi Arabia
por: Hanif, Abdul-Hasseb, et al.
Publicado: (2020)

Successful Treatment of Vancomycin-Resistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents
por: La, Yeon Ju, et al.
Publicado: (2022)

1382. Acute Kidney Injury with Piperacillin–tazobactam and Vancomycin in the Intensive Care Unit
por: Smith, Tameka, et al.
Publicado: (2018)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
por: Alosaimy, Sara, et al.
Publicado: (2020)

Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis
por: Xu, Xiaonan, et al.
Publicado: (2022)

Divergent Effects of Peptidoglycan Carboxypeptidase DacA on Intrinsic β-Lactam and Vancomycin Resistance
por: Park, Si Hyoung, et al.
Publicado: (2022)

Administration and Therapeutic Drug Monitoring of β-lactams and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study
por: Fuentes, Yuli V., et al.
Publicado: (2021)

Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units
por: Matusik, Elodie, et al.
Publicado: (2022)

Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study
por: Park, Chan Sun, et al.
Publicado: (2021)

1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
por: Irusta, Nerea, et al.
Publicado: (2020)

Fish Oil Monotherapy for Intestinal Failure-Associated Liver Disease on SMOFlipid in the Neonatal Intensive Care Unit
por: Lee, Sanghoon, et al.
Publicado: (2020)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit
por: Bhargava, Vidit, et al.
Publicado: (2017)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

Endopeptidase-Mediated Beta Lactam Tolerance
por: Dörr, Tobias, et al.
Publicado: (2015)

Profile of Enterobacteria Resistant to Beta-Lactams
por: Santos, Andressa Liberal, et al.
Publicado: (2020)

Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimens
por: Seok, Hyeri, et al.
Publicado: (2019)

Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry
por: Kim, Min-Hye, et al.
Publicado: (2023)

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)

Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis
por: Chiu, Chia-Yu, et al.
Publicado: (2023)

Severe Thrombocytopenia Caused by Vancomycin in the Intensive Care Unit: A Case Report
por: Li, Xiao-xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ujmvmevuj1i8p3v4frun5vdd3k